Scholar Rock Holding (SRRK) Non Operating Income (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Non Operating Income came in at -$3.5 million in Q1 2026, down 247.61% year-on-year from $2.4 million in Q1 2025, and down 475.3% quarter-over-quarter from $931000.0 in Q4 2025.

Scholar Rock Holding (SRRK) Non Operating Income (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Non Operating Income history runs 10 years deep, the most recent figure standing at -$3.5 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 247.61% year-over-year to -$3.5 million in Q1 2026; TTM through Mar 2026 was $845000.0, a 87.12% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, up 16.42% from the prior year.
  • Non Operating Income retreated to -$3.5 million in Q1 2026 per SRRK's latest filing, from $931000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $2.9 million in Q4 2024 and bottomed at -$3.5 million in Q1 2026.
  • The 5-year median for Non Operating Income is $1.2 million (2023), against an average of $843882.4.
  • Across the five-year window, Non Operating Income surged 341.86% in 2025 and tumbled 247.61% in 2026, its largest moves.
  • Year by year, Non Operating Income stood at $1.2 million in 2022, then jumped by 62.49% to $1.9 million in 2023, then surged by 52.31% to $2.9 million in 2024, then tumbled by 67.93% to $931000.0 in 2025, then slumped by 475.3% to -$3.5 million in 2026.
  • Per Business Quant, the three latest SRRK Non Operating Income figures stand at -$3.5 million (Q1 2026), $931000.0 (Q4 2025), and $1.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -9.22 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 5.75 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -8.59 Mn
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - -3.49 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.49 Mn
Dec 31, 2025 931,000.00
Sep 30, 2025 1.33 Mn
Jun 30, 2025 2.08 Mn
Mar 31, 2025 2.37 Mn
Dec 31, 2024 2.90 Mn
Sep 30, 2024 301,000.00
Jun 30, 2024 990,000.00
Mar 31, 2024 1.57 Mn
Dec 31, 2023 1.91 Mn
Sep 30, 2023 1.31 Mn
Jun 30, 2023 1.16 Mn
Mar 31, 2023 1.13 Mn
Dec 31, 2022 1.17 Mn
Sep 30, 2022 565,000.00
Jun 30, 2022 -853,000.00
Mar 31, 2022 -1.02 Mn
Dec 31, 2021 -550,000.00
Sep 30, 2021 -430,000.00
Jun 30, 2021 -434,000.00